RAFFA WEALTH MANAGEMENT, LLC’s GSK GSK Stock Holding History

RAFFA WEALTH MANAGEMENT, LLC’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$11K	Buy	210 +32	+18%	+$1.69K	﹤0.01%	407
2026 Q1	$9.82K	Hold	178	–	–	﹤0.01%	398
2025 Q4	$8.73K	Buy	178 +64	+56%	+$2.98K	﹤0.01%	397
2025 Q3	$4.92K	Hold	114	–	–	﹤0.01%	489
2025 Q2	$4.38K	Hold	114	–	–	﹤0.01%	529
2025 Q1	$4.42K	Hold	114	–	–	﹤0.01%	450
2024 Q4	$3.85K	Hold	114	–	–	﹤0.01%	500
2024 Q3	$4.66K	Hold	114	–	–	﹤0.01%	432
2024 Q2	$4.39K	Hold	114	–	–	﹤0.01%	560
2024 Q1	$4.89K	Hold	114	–	–	﹤0.01%	515
2023 Q4	$4.22K	Hold	114	–	–	﹤0.01%	423
2023 Q3	$4.13K	Buy	114 +87	+322%	+$3.09K	﹤0.01%	414
2023 Q2	$962	Sell	27 -148	-85%	-$5.31K	﹤0.01%	804
2023 Q1	$6.23K	Hold	175	–	–	﹤0.01%	364
2022 Q4	$6.15K	Sell	175 -147	-46%	-$4.9K	﹤0.01%	352
2022 Q3	$9.48K	Hold	322	–	–	﹤0.01%	288
2022 Q2	$17.5K	Hold	322	–	–	0.01%	217
2022 Q1	$17.6K	Hold	322	–	–	0.01%	230
2021 Q4	$17.8K	Hold	322	–	–	0.01%	231
2021 Q3	$15.4K	Hold	322	–	–	0.01%	214
2021 Q2	$16K	Hold	322	–	–	0.01%	217
2021 Q1	$14.3K	Sell	322 -53	-14%	-$2.41K	0.01%	234
2020 Q4	$17.3K	Hold	375	–	–	0.01%	198
2020 Q3	$17.7K	Hold	375	–	–	0.01%	181
2020 Q2	$19.1K	Hold	375	–	–	0.01%	172
2020 Q1	$17.8K	Hold	375	–	–	0.01%	158
2019 Q4	$22K	Hold	375	–	–	0.01%	188
2019 Q3	$20K	Buy	+375	New	+$19.3K	0.01%	193
2019 Q2	–	Sell	-80	Closed	-$4.18K	–	997
2019 Q1	$4.18K	Hold	80	–	–	﹤0.01%	252
2018 Q4	$3.82K	Hold	80	–	–	﹤0.01%	268
2018 Q3	$4.02K	Hold	80	–	–	﹤0.01%	281
2018 Q2	$4.03K	Hold	80	–	–	﹤0.01%	272
2018 Q1	$3.91K	Hold	80	–	–	﹤0.01%	269
2017 Q4	$3.55K	Hold	80	–	–	﹤0.01%	230
2017 Q3	$4.06K	Hold	80	–	–	﹤0.01%	241
2017 Q2	$4.31K	Hold	80	–	–	﹤0.01%	241
2017 Q1	$4.22K	Sell	80 -50	-38%	-$2.54K	﹤0.01%	221
2016 Q4	$6.28K	Sell	130 -24	-16%	-$1.19K	﹤0.01%	211
2016 Q3	$8.28K	Hold	154	–	–	﹤0.01%	190
2016 Q2	$8.32K	Buy	154 +8	+5%	+$421	﹤0.01%	182
2016 Q1	$7.42K	Hold	146	–	–	﹤0.01%	199
2015 Q4	$7.38K	Buy	146 +12	+9%	+$612	﹤0.01%	188
2015 Q3	$6.46K	Hold	134	–	–	﹤0.01%	203
2015 Q2	$7K	Buy	134 +31	+30%	+$1.75K	﹤0.01%	190
2015 Q1	$5.95K	Hold	103	–	–	﹤0.01%	184
2014 Q4	$5.51K	Hold	103	–	–	﹤0.01%	189
2014 Q3	$5.93K	Buy	103 +23	+29%	+$1.41K	﹤0.01%	189
2014 Q2	$5.35K	Hold	80	–	–	﹤0.01%	182
2014 Q1	$5.34K	Sell	80 -23	-22%	-$1.55K	﹤0.01%	179
2013 Q4	$5.51K	Buy	+103	New	+$6.68K	﹤0.01%	189

Other funds holding GSK

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

TNB

Thomasville National Bank Thomasville, Georgia $1.82B AUM

ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return

CFM

Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return

FVWA

Foster Victor Wealth Advisors Greenville, South Carolina $1.9B AUM 24.46% 1-Year Est. Return

SIS

Sound Income Strategies Ft Lauderdale, Florida $2.23B AUM 11.22% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

KFP

Keystone Financial Planning Cleveland, Ohio $388M AUM 16.66% 1-Year Est. Return

QCM

QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return

Transmarket Holdings Chicago, Illinois $136M AUM

RAFFA WEALTH MANAGEMENT, LLC's GSK Position: Q2 2026 in Review

RAFFA WEALTH MANAGEMENT, LLC increased its GSK (GSK) stake by 18% in Q2 2026, buying an estimated $1.69K and bringing the position to 210 shares worth $11K. The position accounts for ﹤0.01% of the portfolio, ranked #407.

RAFFA WEALTH MANAGEMENT, LLC first reported a position in GSK in Q4 2013 and has held it in 50 quarters since. The position peaked at $22K in Q4 2019. 343 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

RAFFA WEALTH MANAGEMENT, LLC held 210 shares of GSK worth $11K as of Q2 2026.
RAFFA WEALTH MANAGEMENT, LLC bought 32 GSK shares in Q2 2026, an estimated $1.69K.
GSK made up ﹤0.01% of RAFFA WEALTH MANAGEMENT, LLC's portfolio in Q2 2026, its #407 holding.
RAFFA WEALTH MANAGEMENT, LLC first reported a position in GSK in Q4 2013 and has held it in 50 quarters since.
RAFFA WEALTH MANAGEMENT, LLC's GSK position peaked at $22K in Q4 2019.
343 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on RAFFA WEALTH MANAGEMENT, LLC's 13F filing for Q2 2026, filed 27 Jul 2026.